Global Commercial (Conventional and Biotech & GM) Seeds Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture
Publisher : MRA | Format : PDF
Global Commercial (Conventional and Biotech & GM) Seeds Sales Market Report 2024
Market Analysis and InsightsGlobal Commercial (Conventional and Biotech & GM) Seeds Market
With mounting population and consequential increase in food demand, sustainable production of food crops has become the need of the hour. Improved standards of farming coupled with advent of biotechnology in seed cultivation have given a boost to the bioseeds market worldwide leading to disease free cultivation and higher yields.
Due to the COVID-19 pandemic, the global Commercial (Conventional and Biotech & GM) Seeds market size is estimated to be worth US$ 48920 million in 2022 and is forecast to a readjusted size of US$ 73900 million by 2033 with a CAGR of 5.6% during the forecast period 2023-2033. Fully considering the economic change by this health crisis, Maize accounting for % of the Commercial (Conventional and Biotech & GM) Seeds global market in 2022, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Agricultural segment is altered to an % CAGR throughout this forecast period.
The United States Commercial (Conventional and Biotech & GM) Seeds market is estimated at US$ million in 2022, while China was US$ million. The proportion of the United States is % in 2022, while Chinese percentage was %, and it is predicted that China share will reach % in 2033, trailing a CAGR of % through the analysis period.
The global key manufacturers of Commercial (Conventional and Biotech & GM) Seeds include Monsanto, DuPont, Syngenta, Vilmorin & Cie, KWS, Bayer CropScience, Sakata Seed, Takii and AgReliant Genetics, etc. In 2022, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2022, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Commercial (Conventional and Biotech & GM) Seeds Scope and Market Size
The global Commercial (Conventional and Biotech & GM) Seeds market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Commercial (Conventional and Biotech & GM) Seeds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2033.
Segment by Type
Maize
Soybean
Vegetables
Cereals
Cotton
Rice
Canola
Others
Agricultural
Research Institution
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Monsanto
DuPont
Syngenta
Vilmorin & Cie
KWS
Bayer CropScience
Sakata Seed
Takii
AgReliant Genetics
With mounting population and consequential increase in food demand, sustainable production of food crops has become the need of the hour. Improved standards of farming coupled with advent of biotechnology in seed cultivation have given a boost to the bioseeds market worldwide leading to disease free cultivation and higher yields.
Due to the COVID-19 pandemic, the global Commercial (Conventional and Biotech & GM) Seeds market size is estimated to be worth US$ 48920 million in 2022 and is forecast to a readjusted size of US$ 73900 million by 2033 with a CAGR of 5.6% during the forecast period 2023-2033. Fully considering the economic change by this health crisis, Maize accounting for % of the Commercial (Conventional and Biotech & GM) Seeds global market in 2022, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Agricultural segment is altered to an % CAGR throughout this forecast period.
The United States Commercial (Conventional and Biotech & GM) Seeds market is estimated at US$ million in 2022, while China was US$ million. The proportion of the United States is % in 2022, while Chinese percentage was %, and it is predicted that China share will reach % in 2033, trailing a CAGR of % through the analysis period.
The global key manufacturers of Commercial (Conventional and Biotech & GM) Seeds include Monsanto, DuPont, Syngenta, Vilmorin & Cie, KWS, Bayer CropScience, Sakata Seed, Takii and AgReliant Genetics, etc. In 2022, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2022, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Commercial (Conventional and Biotech & GM) Seeds Scope and Market Size
The global Commercial (Conventional and Biotech & GM) Seeds market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Commercial (Conventional and Biotech & GM) Seeds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2033.
Segment by Type
Maize
Soybean
Vegetables
Cereals
Cotton
Rice
Canola
Others
Segment by Application
Agricultural
Research Institution
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Monsanto
DuPont
Syngenta
Vilmorin & Cie
KWS
Bayer CropScience
Sakata Seed
Takii
AgReliant Genetics
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices